Genomics and proteomics analysis of cultured primary rat hepatocytes

Toxicology in Vitro

Volumn 22, Issue 1, 2008, Pages 171-181

  Beigel, Juergen ^a   Fella, Kerstin ^a   Kramer, Peter Juergen ^a   Kroeger, Michaela ^a   Hewitt, Philip ^a  

^a MERCK KGAA   (Germany)

Author keywords

2D Gel electrophoresis; Gene expression; Microarray; Protein expression; Rat primary hepatocytes; SELDI TOF

Indexed keywords

ALPHA 2 MACROGLOBULIN; ALPHA TUBULIN; BETA ACTIN; CATALASE; CLUSTERIN; COLLAGEN; CYTOCHROME P450; CYTOCHROME P450 1A2; FERRITIN; GLUTATHIONE PEROXIDASE; GLUTATHIONE TRANSFERASE; HAPTOGLOBIN; LIPOCORTIN 5; LIPOPOLYSACCHARIDE BINDING PROTEIN; METALLOTHIONEIN; SERINE PROTEINASE INHIBITOR; SERINE PROTEINASE INHIBITOR B; SULFOTRANSFERASE; SUPEROXIDE DISMUTASE; UNCLASSIFIED DRUG; VIMENTIN;

AMINO ACID SEQUENCE; ANIMAL CELL; ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL STRESS; CELL TYPE; CHRONIC TOXICITY; CONTROLLED STUDY; DOWN REGULATION; FIBROBLAST; GENE EXPRESSION; GENOMICS; IN VITRO STUDY; LIVER CELL; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; RAT; STRUCTURAL GENE; TECHNOLOGY; TOXICITY TESTING; XENOBIOTIC METABOLISM;

ANIMAL TESTING ALTERNATIVES; ANIMALS; CELL CULTURE TECHNIQUES; CELLS, CULTURED; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; GENE EXPRESSION REGULATION, ENZYMOLOGIC; GENOMICS; HEPATOCYTES; HUMANS; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEOMICS; RATS; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; TIME FACTORS; TOXICITY TESTS; TOXICOLOGY;

ANIMALIA; RATTUS;

EID: 37249089470     PISSN: 08872333     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tiv.2007.06.019     Document Type: Article

References (43)

1. Ammerschlaeger M., Beigel J., Klein K.U., and Mueller S.O. Characterization of the species-specificity of peroxisome proliferators in rat and human hepatocytes. Toxicol. Sci. 78 (2004) 229-240
2. Baker T.K., Carfagna M.A., Gao H., Dow E.R., Li Q., Searfoss G.H., and Ryan T.P. Temporal gene expression analysis of monolayer cultured rat hepatocytes. Chem. Res. Toxicol. 14 (2001) 1218-1231
3. Barczak A., Rodriguez M.W., Hanspers K., Koth L.L., Tai Y.C., Bolstad B.M., Speed T.P., and Erle D.J. Spotted long oligonucleotide arrays for human gene expression analysis. Genome Res. 13 (2003) 1775-1785
4. Barnes M., Freudenberg J., Thompson S., Aronow B., and Pavlidis P. Experimental comparison and cross-validation of the Affymetrix and Illumina gene expression analysis platforms. Nucleic Acids Res. 33 (2005) 5914-5923
5. Beyer S., Walter Y., Hellmann J., Kramer P.J., Kopp-Schneider A., Kroeger M., and Ittrich C. Comparison of software tools to improve the detection of carcinogen induced changes in the rat liver proteome by analyzing SELDI-TOF-MS spectra. J. Proteome Res. 5 (2006) 254-261
6. Boess F., Kamber M., Romer S., Gasser R., Muller D., Albertini S., and Suter L. Gene expression in two hepatic cell lines, cultured primary hepatocytes, and liver slices compared to the in vivo liver gene expression in rats: possible implications for toxicogenomics use of in vitro systems. Toxicol. Sci. 73 (2003) 386-402
7. Bulera S.J., Eddy S.M., Ferguson E., Jatkoe T.A., Reindel J.F., Bleavins M.R., and De La Iglesia F.A. RNA expression in the early characterization of hepatotoxicants in Wistar rats by high-density DNA microarrays. Hepatology 33 (2001) 1239-1258
8. Chen G., Gharib T.G., Huang C.C., Taylor J.M., Misek D.E., Kardia S.L., Giordano T.J., Iannettoni M.D., Orringer M.B., Hanash S.M., and Beer D.G. Discordant protein and mRNA expression in lung adenocarcinomas. Mol. Cell. Proteomics 1 (2002) 304-313
9. de Longueville F., Surry D., Meneses-Lorente G., Bertholet V., Talbot V., Evrard S., Chandelier N., Pike A., Worboys P., Rasson J.P., Le Bourdelles B., and Remacle J. Gene expression profiling of drug metabolism and toxicology markers using a low-density DNA microarray. Biochem. Pharmacol. 64 (2002) 137-149
10. de Longueville F., Atienzar F.A., Marcq L., Dufrane S., Evrard S., Wouters L., Leroux F., Bertholet V., Gerin B., Whomsley R., Arnould T., Remacle J., and Canning M. Use of a low-density microarray for studying gene expression patterns induced by hepatotoxicants on primary cultures of rat hepatocytes. Toxicol. Sci. 75 (2003) 378-392
11. DiPersio C.M., Jackson D.A., and Zaret K.S. The extracellular matrix coordinately modulates liver transcription factors and hepatocyte morphology. Mol. Cell. Biol. 11 (1991) 4405-4414
12. Fella K., Gluckmann M., Hellmann J., Karas M., Kramer P.J., and Kroger M. Use of two-dimensional gel electrophoresis in predictive toxicology: identification of potential early protein biomarkers in chemically induced hepatocarcinogenesis. Proteomics 5 (2005) 1914-1927
13. Fujita T., Shirasawa T., and Maruyama N. Expression and structure of senescence marker protein-30 (SMP30) and its biological significance. Mech. Ageing Dev. 107 (1999) 271-280
14. Furukawa K., Shimada T., England P., Mochizuki Y., and Williams G.M. Enrichment and characterization of clonogenic epithelial cells from adult rat liver and initiation of epithelial cell strains. In Vitro Cell. Dev. Biol. 23 (1987) 339-348
15. Ghaemmaghami S., Huh W.K., Bower K., Howson R.W., Belle A., Dephoure N., O'Shea E.K., and Weissman J.S. Global analysis of protein expression in yeast. Nature 425 (2003) 737-741
16. Greenbaum D., Colangelo C., Williams K., and Gerstein M. Comparing protein abundance and mRNA expression levels on a genomic scale. Genome Biol. 4 (2003) 117
17. Green J.R., Seltenmeyer Y., Jaeggi K.A., and Widler L. Renal tolerability profile of novel, potent bisphosphonates in two short-term rat models. Pharmacol. Toxicol. 80 (1997) 225-230
18. Gruys E., Toussaint M.J., Niewold T.A., and Koopmans S.J. Acute phase reaction and acute phase proteins. J. Zhejiang Univ. Sci. B 6 (2005) 1045-1056
19. Guengerich F.P. Cytochromes P450, drugs, and diseases. Mol. Interv. 3 (2003) 194-204
20. Gygi S.P., Rochon Y., Franza B.R., and Aebersold R. Correlation between protein and mRNA abundance in yeast. Mol. Cell. Biol. 19 (1999) 1720-1730
21. Hamadeh H.K., Bushel P.R., Jayadev S., DiSorbo O., Bennett L., Li L., Tennant R., Stoll R., Barrett J.C., Paules R.S., Blanchard K., and Afshari C.A. Prediction of compound signature using high density gene expression profiling. Toxicol. Sci. 67 (2002) 232-240
22. Harris A.J., Dial S.L., and Casciano D.A. Comparison of basal gene expression profiles and effects of hepatocarcinogens on gene expression in cultured primary human hepatocytes and HepG2 cells. Mutat. Res. 549 (2004) 79-99
23. Hartl F.U., and Martin J. Molecular chaperones in cellular protein folding. Curr. Opin. Struct. Biol. 5 (1995) 92-102
24. Heinloth A.N., Irwin R.D., Boorman G.A., Nettesheim P., Fannin R.D., Sieber S.O., Snell M.L., Tucker C.J., Li L., Travlos G.S., Vansant G., Blackshear P.E., Tennant R.W., Cunningham M.L., and Paules R.S. Gene expression profiling of rat livers reveals indicators of potential adverse effects. Toxicol. Sci. 80 (2004) 193-202
25. Jarvinen A.K., Hautaniemi S., Edgren H., Auvinen P., Saarela J., Kallioniemi O.P., and Monni O. Are data from different gene expression microarray platforms comparable?. Genomics 83 (2004) 1164-1168
26. Kienhuis A.S., Wortelboer H.M., Maas W.J., van Herwijnen M., Kleinjans J.C., van Delft J.H., and Stierum R.H. Sandwich-cultured rat hepatocyte system with increased metabolic competence evaluated by gene expression profiling. Toxicol. In Vitro 21 5 (2007) 892-901
27. Kothapalli R., Yoder S.J., Mane S., and Loughran Jr. T.P. Microarray results: how accurate are they?. BMC Bioinformatics 3 (2002) 22
28. Kroger M., Hellmann J., Toldo L., Gluckmann M., von Eiff B., Fella K., and Kramer P.J. Toxicoproteomics: first experiences in a BMBF-study. Altex 21 Suppl. 3 (2004) 28-40
29. Kuo W.P., Jenssen T.K., Butte A.J., Ohno-Machado L., and Kohane I.S. Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics 18 (2002) 405-412
30. Larkin J.E., Frank B.C., Gavras H., Sultana R., and Quackenbush J. Independence and reproducibility across microarray platforms. Nat. Meth. 2 (2005) 337-344
31. Mah N., Thelin A., Lu T., Nikolaus S., Kuhbacher T., Gurbuz Y., Eickhoff H., Kloppel G., Lehrach H., Mellgard B., Costello C.M., and Schreiber S. A comparison of oligonucleotide and cDNA-based microarray systems. Physiol. Genomics 16 (2004) 361-370
32. Mazzulli T., Low D.E., and Poutanen S.M. Proteomics and severe acute respiratory syndrome (SARS): emerging technology meets emerging pathogen. Clin. Chem. 51 (2005) 6-7
33. Mitsumoto A., Takeuchi A., Okawa K., and Nakagawa Y. A subset of newly synthesized polypeptides in mitochondria from human endothelial cells exposed to hydroperoxide stress. Free Radic. Biol. Med. 32 (2002) 22-37
34. Seglen P.O. Preparation of isolated rat liver cells. Meth. Cell. Biol. 13 (1976) 29-83
35. Shi L., Reid L.H., Jones W.D., Shippy R., Warrington J.A., Baker S.C., Collins P.J., de Longueville F., Kawasaki E.S., Lee K.Y., Luo Y., Sun Y.A., Willey J.M., Setterquist R.A., Fischer G.M., Tong W., Dragan Y.P., Dix D.J., Frueh F.W., Goodsaid F.M., Herman D., Jensen R.V., Johnson C.D., Lobenhofer E.K., Puri R.K., Schrf U., Thierry-Mieg J., Wang C., Wilson M., Wolber P.K., Zhang L., and Slikker Jr. W. The MicroArray Quality Control (MAQC) project shows inter- and intraplatform reproducibility of gene expression measurements. Nat. Biotechnol. 24 (2006) 1151-1161
36. Shippy R., Sendera T.J., Lockner R., Palaniappan C., Kaysser-Kranich T., Watts G., and Alsobrook J. Performance evaluation of commercial short-oligonucleotide microarrays and the impact of noise in making cross-platform correlations. BMC Genomics 5 (2004) 61
37. Tapia G., Fernandez V., Pino C., Ardiles R., and Videla L.A. The acute-phase response of the liver in relation to thyroid hormone-induced redox signaling. Free Radic. Biol. Med. 40 (2006) 1628-1635
38. Thomas R.S., Rank D.R., Penn S.G., Zastrow G.M., Hayes K.R., Pande K., Glover E., Silander T., Craven M.W., Reddy J.K., Jovanovich S.B., and Bradfield C.A. Identification of toxicologically predictive gene sets using cDNA microarrays. Mol. Pharmacol. 60 (2001) 1189-1194
39. Thome-Kromer B., Bonk I., Klatt M., Nebrich G., Taufmann M., Bryant S., Wacker U., and Kopke A. Toward the identification of liver toxicity markers: a proteome study in human cell culture and rats. Proteomics 3 (2003) 1835-1862
40. Waring J.F., Ciurlionis R., Jolly R.A., Heindel M., and Ulrich R.G. Microarray analysis of hepatotoxins in vitro reveals a correlation between gene expression profiles and mechanisms of toxicity. Toxicol. Lett. 120 (2001) 359-368
41. Waring J.F., Jolly R.A., Ciurlionis R., Lum P.Y., Praestgaard J.T., Morfitt D.C., Buratto B., Roberts C., Schadt E., and Ulrich R.G. Clustering of hepatotoxins based on mechanism of toxicity using gene expression profiles. Toxicol. Appl. Pharmacol. 175 (2001) 28-42
42. Wetmore B.A., and Merrick B.A. Toxicoproteomics: proteomics applied to toxicology and pathology. Toxicol. Pathol. 32 (2004) 619-642
43. Yuen T., Wurmbach E., Pfeffer R.L., Ebersole B.J., and Sealfon S.C. Accuracy and calibration of commercial oligonucleotide and custom cDNA microarrays. Nucleic Acids Res. 30 (2002) e48